|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
British Columbia Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing British ColumbiaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Bioasis Technologies, Inc.
| | | Phone: | (604) 295-7014 | Year Established: | 2006 | Ticker: | BIOAF | Exchange: | OTCQB | Main Contact: | Mark Day, Ph.D., President & CEO | | Other Contacts: | Christopher P. Lowe, M.B.A., CFO Mei Mei Tian, Ph.D., VP, Head of External Research
| | Company Description | Bioasis Technologies is a biopharmaceutical company focused on the delivery of therapeutics across the blood-brain barrier (BBB) and into the central nervous system for the treatment of neurological diseases and disorders. The delivery of therapeutics across the BBB represents the single greatest challenge in treating neurological disorders. The company is developing and commercializing the xB3™ platform, Bioasis’ proprietary blood-brain barrier delivery technology, to address unmet medical needs in the treatment of central nervous system diseases and disorders. | |
|
|
|
|
|